BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that democratizes data-driven medicine, today announced that Ken Freedman has been appointed Chief Revenue Officer. With a background in serving some of the most innovative providers of technology to the world-wide media space, Ken brings more than […]

The funding will drive international deployment of the company’s next generation genomic analysis platform to enable personalized medicine in cancers as well as rare and hereditary diseases. Montpellier – SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine today announced a Series A funding round of €20M.  The round, led by Omnes, Merieux […]

myCurio™ Accelerates Plant Genomics Research & Development ANN ARBOR, MICHIGAN, UNITED STATES — Curio Genomics and Daicel Arbor Biosciences announced the launch of the cloud-based bioinformatics platform myCurio™, resulting from their multi-year product development and marketing partnership. The integration of myCurio into Arbor’s industry-recognized myBaits™ and myReads™ custom NGS products and services provides unique and powerful […]

Sean Kearney Joins Executive Team to Help Drive Continued Growth in Genomic Data Business ANN ARBOR, MICH. — Following a year of 125% revenue growth, Genomenon®, Inc., an AI-driven genomics company, today announced that Sean Kearney has been appointed Chief Financial Officer (CFO), effective immediately. As a valuable member of Genomenon’s executive leadership team, Mr. Kearney […]

Partnership enables comprehensive clinical information to deliver optimal patient care ST. LOUIS, MO — PierianDx, the global leader in clinical genomics knowledge, today announced that it has partnered with Biodesix to provide its interpretation technology platform for use with the Biodesix newly launched GeneStrat NGS™ genomic test, a blood-based tumor profiling test to detect actionable mutations in patients […]

Accelerates company’s long-term growth strategy and the evolution of its industry-leading clinico-genomic data capabilities TAMPA, FL — M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry leading data and analytics, today announced that it has expanded its executive team with the appointments of Daniel Elgort, Ph.D., as Chief Data and Analytics Officer and May Yoon as […]

Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces the expansion of its range of clinical consulting services. In addition to the services  already offered by Congenica, the Company has launched a new “sample to report” service, providing additional access to sequence […]

Discngine, a research and lab informatics software and services company, announces a strategic partnership with ChemAxon, a leading cheminformatics and bioinformatics company. By joining forces, the partners expect to streamline pharma and biotech research involving complex biomolecular structural data. Paris —Discngine’s 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base. Its fundamental value […]

Enables sharing of, and access to, novel datasets and tools through Eagle Genomics’ e[datascientist]™ platform Agreement will facilitate understanding of complex relationships between microbiome, food and other factors, including potential causes of health and disease CAMBRIDGE and NORWICH, UK — Today, Eagle Genomics, the Deep Tech software business pioneering the application of network science to biology, and the Quadram […]

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Since study launch, 12 sites across 5 countries have already signed up for participation BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the […]